CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Feb. 27, 2020—Qiagen announced it has shipped its newly developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation and is in the process of shipping QIAstat-Dx testing kits to public health institutions in other regions, including Europe, Southeast Asia, and the Middle East.
The panel is a new version of the existing QIAstat-Dx Respiratory Panel for differential analysis of 21 viral and bacterial pathogens in respiratory syndromes. Once the SARS-CoV-2 genome was sequenced in January, the company developed two highly sensitive assays to detect SARS-CoV-2 targeting Orb1ab and the E gene.
Pages: 1 2